Indikationserweiterungen von Rhabarberwurzel und Vitamin D Vom Labor in die Klinik

[1] Fine JD(2014)Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification J Am Acad Dermatol 70 1103-1126

[2] Bruckner-Tuderman L(2003)Generation and characterization of epidermolysis bullosa simplex cell lines: scratch assays show faster migration with disruptive keratin mutations Br J Dermatol 149 46-58

[3] Eady RAJ(2013)The Pathogenetic Role of IL-1β in Severe Epidermolysis Bullosa Simplex J Invest Dermatol 133 1901-1903

[4] Morley V(2013)Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study Orphanet J Rare Dis 8 69-28

[5] Wally T(2010)Common wound colonizers in patients with epidermolysis bullosa Pediatr Dermatol 27 25-173

[6] Lettner P(2016)Antimicrobial peptides and wound healing: biological and therapeutic considerations Exp Dermatol 25 167-742

[7] Peking V(2012)Induction of the human cathelicidin LL-37 as a novel treatment against bacterial infections J Leukoc Biol 92 735-389

[8] Wally S(2003)The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium J Invest Dermatol 120 379-4668

[9] Kitzmueller F(2005)Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37 J Immunol 175 4662-1672

[10] Lagler HA(2003)An angiogenic role for the human peptide antibiotic LL-37/hCAP-18 J Clin Invest 11 1665-236

[1] Fine JD(2014)Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification J Am Acad Dermatol 70 1103-1126

[2] Bruckner-Tuderman L(2003)Generation and characterization of epidermolysis bullosa simplex cell lines: scratch assays show faster migration with disruptive keratin mutations Br J Dermatol 149 46-58

[3] Eady RAJ(2013)The Pathogenetic Role of IL-1β in Severe Epidermolysis Bullosa Simplex J Invest Dermatol 133 1901-1903

[4] Morley V(2013)Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study Orphanet J Rare Dis 8 69-28

[5] Wally T(2010)Common wound colonizers in patients with epidermolysis bullosa Pediatr Dermatol 27 25-173

[6] Lettner P(2016)Antimicrobial peptides and wound healing: biological and therapeutic considerations Exp Dermatol 25 167-742

[7] Peking V(2012)Induction of the human cathelicidin LL-37 as a novel treatment against bacterial infections J Leukoc Biol 92 735-389

[8] Wally S(2003)The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium J Invest Dermatol 120 379-4668

[9] Kitzmueller F(2005)Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37 J Immunol 175 4662-1672

[10] Lagler HA(2003)An angiogenic role for the human peptide antibiotic LL-37/hCAP-18 J Clin Invest 11 1665-236